TC BIOPHARM HOLDINGS PLC Stock Price, News & Analysis
TCBPW
NASDAQ
Company Description
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (GD-T) cell platform. With an innate ability to combat cancer and viral infection, the company's clinical-stage cell therapies are at the forefront of innovation.
Stock Performance
$—
0.00%
0.00
Last updated:
-86.49 %
Performance 1 year
$0.0
Market Cap
5.0M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for TC BIOPHARM HOLDINGS PLC.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of TC BIOPHARM HOLDINGS PLC (TCBPW)?
The current stock price of TC BIOPHARM HOLDINGS PLC (TCBPW) is $0.006 as of March 21, 2025.
What is TC BioPharm (Holdings) PLC focused on?
The company is focused on developing immunotherapy products based on its proprietary allogeneic gamma delta T cell platform.
What makes the company's gamma delta T cell therapies unique?
TC BioPharm's therapies harness the innate ability of gamma delta T cells to combat cancer and viral infections.
What are some recent achievements of TC BioPharm (Holdings) PLC?
The company is the leader in developing gamma delta T cell therapies and has conducted phase II/pivotal clinical studies in oncology.
What clinical trials is TC BioPharm currently conducting?
The company is conducting two investigator-initiated clinical trials for its gamma-delta T cell product line, including a Phase 2b/3 pivotal trial for OmnImmune® in treating acute myeloid leukemia.
Does TC BioPharm have a manufacturing facility?
Yes, the company owns its manufacturing facility to maintain cost and product quality controls.
What is TC BioPharm's approach to targeting tumors?
TC BioPharm uses an allogeneic approach to effectively identify, target, and eradicate both liquid and solid tumors in cancer.
Who is the Chief Executive Officer of TC BioPharm (Holdings) PLC?
Bryan Kobel is the Chief Executive Officer of the company.
What is the Big Biz Show, and why was TC BioPharm featured on it?
The Big Biz Show is an Emmy Award-winning nationally syndicated program, and TC BioPharm's CEO was featured in a live interview for the show to discuss the company's developments in gamma delta T cell therapies for cancer treatment.
What is TC BioPharm's stance on forward-looking statements?
The company acknowledges the inherent uncertainties in predicting future results and conditions and undertakes no obligation to revise or update any forward-looking statements.
Where can I find more information about TC BioPharm (Holdings) PLC?
For more information, visit the company's official website at TC BioPharm.